Sarepta Therapeutics | Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Amgen USD 52.43B 1.33B 2025-09
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 6.69B 2025-09
Gilead Sciences USD 22.14B 5M 2025-09
Incyte USD 35.37M 3.61M 2025-09
Insmed USD 539.72M 21.23M 2025-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Moderna USD 26M 6M 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Tectonic Therapeutic USD 100K 86K 2025-09
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03


Sarepta Therapeutics Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.